Table II.

Several histone modification genes altered in various cancers.

Authors, year	Cancer type	Methylated genes	Refs.
Reinert, 2012	Bladder cancer	ZNF154, HOXA9, POU4F2, TWIST1, VIM	(32)
de Groot et al, 2014	Breast cancer	SLC5A8, AKR1B1, ALX1, GPX7, RASSGRF2, SFRP2, TM6SF1 and TMEFF2	(33)
Yi, 2021	Colorectal cancer	TFPI2, FBN2, SEPT9, SMAP8, MLH1, CDH1, TIMP3, O6-MGMT, SFRP1, SFRP2, p16, APC, HIC1, CHFR	(34)
Etcheverry et al, 2010; LeBlanc and Marra, 2016	Glioblastoma	SLC5A8, MGMT, SOX10, RUNX3, WIF1, CD133, HTATIP2, PDE4C, TES	(35,36)
Zhang et al, 2016	Hepatocellular carcinoma	RASSF1A, APC, GSTP1, CDH1, p15, RUNX3, SOCS1, SFRP1, PRDM2, p14, RARβ and p73	(37)
Shen et al, 2019	Lung cancer	SLC5A8, HOXA9, KRTAP8-1, CCND1, TULP2	(38)
Yang and Park, 2012	Prostate cancer	CAV1, CDKN2A, CCND2, DAPK, HIC1, LPL, PITX2, PTGS2, RASSF1A, SLC5A8	(39)